A 12 Week Study to Confirm the Effectiveness of 8mg of Fesoterodine Compared to 4mg of Fesoterodine

NCT01302067 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

2012

Enrollment

INDUSTRY

Sponsor class

Conditions

Overactive Bladder

Interventions

DRUG: Fesoterodine 8mg
DRUG: Fesoterodine 4mg
DRUG: Placebo

Sponsor

Pfizer